KYMR   $44.98  3.38% Market Closed After Close 44.98 0.0

Kymera Therapeutics Inc
Total Cash 549.97M
totalCashPerShare 8.492
EBITDA -190.49M
Total Debt 88.23M
quickRatio 8.286
currentRatio 8.548
Total Revenue 87.56M
debtToEquity 9.881
Revenue/Share 1.258
ROA -0.15378
ROE -0.25996
grossProfits
freeCashflow -94.10M
operatingCashflow -124.67M
earningsGrowth
revenueGrowth -0.209
grossMargins -1.52848
ebitdaMargins -2.17546
operatingMargins -19.279339
profitMargins -1.91261
enterpriseValue 2.63B
forwardPE -15.808306
floatShares 43.99M
sharesOutstanding 64.77M
sharesShort 9.07M
sharesShortPriorMonth 9.49M
dateShortInterest
sharesPercentSharesOut 0.14%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.05%
Short Ratio help_outline 19.45%
shortPercentOfFloat 0.16%
impliedSharesOutstanding
bookValue 13.791
Price To Book help_outline 3.59
earningsQuarterlyGrowth
netIncomeToCommon -167.47M
trailingEps -2.34%
forwardEps -3.13%
enterpriseToEbitda -13.79
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.77 4Q 2024
institutionsCount 243
lastUpdated Nov. 7, 2024, 3:23 a.m.